These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
253 related articles for article (PubMed ID: 34763028)
1. Combination of the 6-thioguanine and disulfiram/Cu synergistically inhibits proliferation of triple-negative breast cancer cells by enhancing DNA damage and disrupting DNA damage checkpoint. Chu M; An X; Zhang D; Li Q; Dai X; Yu H; Li Z Biochim Biophys Acta Mol Cell Res; 2022 Feb; 1869(2):119169. PubMed ID: 34763028 [TBL] [Abstract][Full Text] [Related]
2. Suppressing autophagy enhances disulfiram/copper-induced apoptosis in non-small cell lung cancer. Wu X; Xue X; Wang L; Wang W; Han J; Sun X; Zhang H; Liu Y; Che X; Yang J; Wu C Eur J Pharmacol; 2018 May; 827():1-12. PubMed ID: 29547841 [TBL] [Abstract][Full Text] [Related]
3. Disulfiram targets cancer stem-like properties and the HER2/Akt signaling pathway in HER2-positive breast cancer. Kim JY; Cho Y; Oh E; Lee N; An H; Sung D; Cho TM; Seo JH Cancer Lett; 2016 Aug; 379(1):39-48. PubMed ID: 27238567 [TBL] [Abstract][Full Text] [Related]
4. Disulfiram combined with copper inhibits metastasis and epithelial-mesenchymal transition in hepatocellular carcinoma through the NF-κB and TGF-β pathways. Li Y; Wang LH; Zhang HT; Wang YT; Liu S; Zhou WL; Yuan XZ; Li TY; Wu CF; Yang JY J Cell Mol Med; 2018 Jan; 22(1):439-451. PubMed ID: 29148232 [TBL] [Abstract][Full Text] [Related]
5. Disulfiram induces anoikis and suppresses lung colonization in triple-negative breast cancer via calpain activation. Kim JY; Lee N; Kim YJ; Cho Y; An H; Oh E; Cho TM; Sung D; Seo JH Cancer Lett; 2017 Feb; 386():151-160. PubMed ID: 27894956 [TBL] [Abstract][Full Text] [Related]
6. Disulfiram/copper markedly induced myeloma cell apoptosis through activation of JNK and intrinsic and extrinsic apoptosis pathways. Xu Y; Zhou Q; Feng X; Dai Y; Jiang Y; Jiang W; Liu X; Xing X; Wang Y; Ni Y; Zheng C Biomed Pharmacother; 2020 Jun; 126():110048. PubMed ID: 32145587 [TBL] [Abstract][Full Text] [Related]
7. Disulfiram/copper shows potent cytotoxic effects on myelodysplastic syndromes via inducing Bip-mediated apoptosis and suppressing autophagy. Zha J; Bi S; Deng M; Chen K; Shi P; Feng L; He J; Pu X; Guo C; Zhao H; Li Z; Jiang Y; Song H; Xu B Eur J Pharmacol; 2021 Jul; 902():174107. PubMed ID: 33865831 [TBL] [Abstract][Full Text] [Related]
8. The disulfiram/copper complex induces apoptosis and inhibits tumour growth in human osteosarcoma by activating the ROS/JNK signalling pathway. Guo W; Zhang X; Lin L; Wang H; He E; Wang G; Zhao Q J Biochem; 2021 Oct; 170(2):275-287. PubMed ID: 33792698 [TBL] [Abstract][Full Text] [Related]
9. Differential Cytotoxicity Mechanisms of Copper Complexed with Disulfiram in Oral Cancer Cells. Chen SY; Chang YL; Liu ST; Chen GS; Lee SP; Huang SM Int J Mol Sci; 2021 Apr; 22(7):. PubMed ID: 33918312 [TBL] [Abstract][Full Text] [Related]
10. Disulfiram/Copper Induce Ferroptosis in Triple-Negative Breast Cancer Cell Line MDA-MB-231. Chu M; An X; Fu C; Yu H; Zhang D; Li Q; Man X; Dai X; Li Z Front Biosci (Landmark Ed); 2023 Aug; 28(8):186. PubMed ID: 37664913 [TBL] [Abstract][Full Text] [Related]
11. Disulfiram inhibits TGF-β-induced epithelial-mesenchymal transition and stem-like features in breast cancer via ERK/NF-κB/Snail pathway. Han D; Wu G; Chang C; Zhu F; Xiao Y; Li Q; Zhang T; Zhang L Oncotarget; 2015 Dec; 6(38):40907-19. PubMed ID: 26517513 [TBL] [Abstract][Full Text] [Related]
12. Disulfiram Acts as a Potent Radio-Chemo Sensitizer in Head and Neck Squamous Cell Carcinoma Cell Lines and Transplanted Xenografts. Yao W; Qian X; Ochsenreither S; Soldano F; DeLeo AB; Sudhoff H; Oppel F; Kuppig A; Klinghammer K; Kaufmann AM; Albers AE Cells; 2021 Feb; 10(3):. PubMed ID: 33671083 [TBL] [Abstract][Full Text] [Related]
13. Indole-2-Carboxamide Derivative LG25 Inhibits Triple-Negative Breast Cancer Growth By Suppressing Akt/mTOR/NF-κB Signalling Pathway. Xu X; Rajamanickam V; Shu S; Liu Z; Yan T; He J; Liu Z; Guo G; Liang G; Wang Y Drug Des Devel Ther; 2019; 13():3539-3550. PubMed ID: 31631978 [TBL] [Abstract][Full Text] [Related]
14. Disulfiram treatment facilitates phosphoinositide 3-kinase inhibition in human breast cancer cells in vitro and in vivo. Zhang H; Chen D; Ringler J; Chen W; Cui QC; Ethier SP; Dou QP; Wu G Cancer Res; 2010 May; 70(10):3996-4004. PubMed ID: 20424113 [TBL] [Abstract][Full Text] [Related]
15. Disulfiram and BKM120 in Combination with Chemotherapy Impede Tumor Progression and Delay Tumor Recurrence in Tumor Initiating Cell-Rich TNBC. Wu L; Meng F; Dong L; Block CJ; Mitchell AV; Wu J; Jang H; Chen W; Polin L; Yang Q; Dou QP; Wu G Sci Rep; 2019 Jan; 9(1):236. PubMed ID: 30659204 [TBL] [Abstract][Full Text] [Related]
16. CHK1 and CHK2 are differentially involved in mismatch repair-mediated 6-thioguanine-induced cell cycle checkpoint responses. Yan T; Desai AB; Jacobberger JW; Sramkoski RM; Loh T; Kinsella TJ Mol Cancer Ther; 2004 Sep; 3(9):1147-57. PubMed ID: 15367709 [TBL] [Abstract][Full Text] [Related]
17. Disulfiram/copper induces antitumor activity against gastric cancer cells in vitro and in vivo by inhibiting S6K1 and c-Myc. Du C; Guan X; Liu Y; Xu Z; Du X; Li B; Wang M; Zheng Z Cancer Chemother Pharmacol; 2022 Apr; 89(4):451-458. PubMed ID: 35201421 [TBL] [Abstract][Full Text] [Related]
18. Targeting ALDH2 with disulfiram/copper reverses the resistance of cancer cells to microtubule inhibitors. Wang NN; Wang LH; Li Y; Fu SY; Xue X; Jia LN; Yuan XZ; Wang YT; Tang X; Yang JY; Wu CF Exp Cell Res; 2018 Jan; 362(1):72-82. PubMed ID: 29155365 [TBL] [Abstract][Full Text] [Related]
19. Antitumor effects of disulfiram/copper complex in the poorly-differentiated nasopharyngeal carcinoma cells via activating ClC-3 chloride channel. Xu X; Xu J; Zhao C; Hou X; Li M; Wang L; Chen L; Chen Y; Zhu L; Yang H Biomed Pharmacother; 2019 Dec; 120():109529. PubMed ID: 31606620 [TBL] [Abstract][Full Text] [Related]
20. Intestinal microbiota regulates anti-tumor effect of disulfiram combined with Cu Hu H; Cui L; Lu J; Wei K; Wei J; Li S; Zou C; Chen T Cancer Med; 2020 Sep; 9(18):6791-6801. PubMed ID: 32750218 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]